These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11408224)

  • 21. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.
    Roberts WL; Berman JD; Rainey PM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1234-9. PubMed ID: 7574507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5'-Trityl-substituted thymidine derivatives as a novel class of antileishmanial agents: Leishmania infantum EndoG as a potential target.
    Casanova E; Moreno D; Gigante A; Rico E; Genes CM; Oliva C; Camarasa MJ; Gago F; Jiménez-Ruiz A; Pérez-Pérez MJ
    ChemMedChem; 2013 Jul; 8(7):1161-74. PubMed ID: 23625887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.
    Holzmuller P; Sereno D; Lemesre JL
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4406-9. PubMed ID: 16189135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced antimony accumulation in ARM58-overexpressing Leishmania infantum.
    Schäfer C; Tejera Nevado P; Zander D; Clos J
    Antimicrob Agents Chemother; 2014; 58(3):1565-74. PubMed ID: 24366738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
    Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
    Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
    Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
    Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.
    Holzmuller P; Cavaleyra M; Moreaux J; Kovacic R; Vincendeau P; Papierok G; Lemesre JL
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):247-57. PubMed ID: 15963823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.
    Lizarazo-Jaimes EH; Reis PG; Bezerra FM; Rodrigues BL; Monte-Neto RL; Melo MN; Frézard F; Demicheli C
    J Inorg Biochem; 2014 Mar; 132():30-6. PubMed ID: 24412095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum.
    Rochette A; Raymond F; Corbeil J; Ouellette M; Papadopoulou B
    Mol Biochem Parasitol; 2009 May; 165(1):32-47. PubMed ID: 19393160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania infantum: antiproliferative effect of recombinant plant cystatins on promastigotes and intracellular amastigotes estimated by direct counting and real-time PCR.
    Ordóñez-Gutiérrez L; Martínez M; Rubio-Somoza I; Díaz I; Mendez S; Alunda JM
    Exp Parasitol; 2009 Dec; 123(4):341-6. PubMed ID: 19723520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients.
    Inocêncio da Luz R; Romero GA; Dorval ME; Cruz I; Cañavate C; Dujardin JC; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Mar; 66(3):677-9. PubMed ID: 21393233
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
    Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
    Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.
    Tempone AG; Perez D; Rath S; Vilarinho AL; Mortara RA; de Andrade HF
    J Antimicrob Chemother; 2004 Jul; 54(1):60-8. PubMed ID: 15163652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel polysubstituted (2SR,4RS)-2-heteroaryltetrahydro-1,4-epoxy-1-benzazepines and cis-2-heteroaryl-4-hydroxytetrahydro-1H-1-benzazepines as antiparasitic agents.
    Blanco MC; Escobar P; Leal SM; Bahsas A; Cobo J; Nogueras M; Palma A
    Eur J Med Chem; 2014 Oct; 86():291-309. PubMed ID: 25173828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel α- and nor-α-lapachone-based 1,2,3-triazoles by copper-catalyzed azide-alkyne cycloaddition.
    Guimarães TT; Pinto Mdo C; Lanza JS; Melo MN; do Monte-Neto RL; de Melo IM; Diogo EB; Ferreira VF; Camara CA; Valença WO; de Oliveira RN; Frézard F; da Silva EN
    Eur J Med Chem; 2013 May; 63():523-30. PubMed ID: 23535320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania.
    Holzmuller P; Bras-Gonçalves R; Lemesre JL
    Parasitology; 2006; 132 Suppl():S19-32. PubMed ID: 17018162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes.
    Marinho FA; Gonçalves KC; Oliveira SS; Gonçalves DS; Matteoli FP; Seabra SH; Oliveira AC; Bellio M; Oliveira SS; Souto-Padrón T; d'Avila-Levy CM; Santos AL; Branquinha MH
    PLoS One; 2014; 9(1):e87659. PubMed ID: 24498160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.